Press "Enter" to skip to content

New patent expiration for Kastle Theraps drug KYNAMRO

0
Copyright © DrugPatentWatch. Originally published at New patent expiration for Kastle Theraps drug KYNAMRO

Annual Drug Patent Expirations for KYNAMRO
Annual Drug Patent Expirations for KYNAMRO

Kynamro is a drug marketed by Kastle Theraps Llc and is included in one NDA. There are four patents protecting this drug.

This drug has five hundred and twenty-eight patent family members in nineteen countries.

The generic ingredient in KYNAMRO is mipomersen sodium. Additional details are available on the mipomersen sodium profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent expiration for Kastle Theraps drug KYNAMRO
Get the DrugPatentWatch Daily Briefing

✓ Patent Expirations and Generic Entry

✓ Insightful Articles & Case Studies

✓ Patent Litigation & Challenges

✓ 505(b)(2) & Biosimilars

✓ Industry Trends

DrugPatentWatch - Make Better Decisions